{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:33:46Z","timestamp":1773423226703,"version":"3.50.1"},"reference-count":5,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["Indian J Dermatol Venereol Leprol"],"DOI":"10.25259\/ijdvl_300_2024","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T04:01:38Z","timestamp":1729310498000},"page":"221-223","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute painless loss of vision due to bilateral hemiretinal vein occlusion in a case of bullous pemphigoid on tofacitinib: A potentially red flag symptom"],"prefix":"10.25259","volume":"92","author":[{"given":"Kumari","family":"Ritu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavin","family":"Bhogar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taru","family":"Dewan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"10.25259\/IJDVL_300_2024\/ref-1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdcr.2022.10.028","article-title":"Two cases of bullous pemphigoid effectively treated with oral tofacitinib","volume":"32","author":"Youssef","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.25259\/IJDVL_300_2024\/ref-2","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3390\/ijms22052449","article-title":"Thromboembolic adverse drug reactions in janus kinase (JAK) inhibitors: Does the inhibitor specificity play a role?","volume":"22","author":"Kotyla","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.25259\/IJDVL_300_2024\/ref-3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12348-023-00359-w","article-title":"Branch retinal vein occlusion in a case of recalcitrant diffuse anterior scleritis treated with tofacitinib","volume":"13","author":"Manoharan","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.25259\/IJDVL_300_2024\/ref-4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jama.2019.9055","article-title":"Effect of filgotinib vs placebo on clinical response in patients with moderate to severe rheumatoid arthritis refractory to disease-modifying antirheumatic drug therapy: The FINCH 2 randomized clinical trial","volume":"322","author":"Genovese","year":"2019","journal-title":"JAMA"},{"key":"10.25259\/IJDVL_300_2024\/ref-5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ueg2.12492","article-title":"Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study","volume":"12","author":"Allocca","year":"2024","journal-title":"United European Gastroenterol J"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/acute-painless-loss-of-vision-due-to-bilateral-hemiretinal-vein-occlusion-in-a-case-of-bullous-pemphigoid-on-tofacitinib-a-potentially-red-flag-symptom\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/acute-painless-loss-of-vision-due-to-bilateral-hemiretinal-vein-occlusion-in-a-case-of-bullous-pemphigoid-on-tofacitinib-a-potentially-red-flag-symptom\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:34:08Z","timestamp":1772868848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/acute-painless-loss-of-vision-due-to-bilateral-hemiretinal-vein-occlusion-in-a-case-of-bullous-pemphigoid-on-tofacitinib-a-potentially-red-flag-symptom\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":5,"alternative-id":["10.25259\/IJDVL_300_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_300_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"221"}}